logomg.png
Open an Account
Open an Account
  • Ripple-loading

  • SENSEX

    {{sensexData[0].price}} (+{{sensexData[0].change}}%)

  • SENSEX

    {{sensexData[0].price}} ({{sensexData[0].change}}%)

  • Ripple-loading

  • NIFTY 50

    {{niftyData[0].open_price}} (+{{niftyData[0].change}}%)

  • NIFTY 50

    {{niftyData[0].open_price}} ({{niftyData[0].change}}%)

  • Ripple-loading

  • {{mcxData[2].symbol}}

    {{mcxData[2].price}} (+{{mcxData[2].PerChange}}%)

  • {{mcxData[2].symbol}}

    {{mcxData[2].price}} ({{mcxData[2].PerChange}}%)

  • {{mcxData[0].symbol}}

    {{mcxData[0].price}} (+{{mcxData[0].PerChange}}%)

  • {{mcxData[0].symbol}}

    {{mcxData[0].price}} ({{mcxData[0].PerChange}}%)

  • Ripple-loading

  • {{mcxData[1].symbol}}

    {{mcxData[1].price}} (+{{mcxData[1].PerChange}}%)

  • {{mcxData[1].symbol}}

    {{mcxData[1].price}} ({{mcxData[1].PerChange}}%)

  • Ripple-loading

  • {{mcxData[3].symbol}}

    {{mcxData[3].price}} (+{{mcxData[3].PerChange}}%)

  • {{mcxData[3].symbol}}

    {{mcxData[3].price}} ({{mcxData[3].PerChange}}%)

Nephrocare Health Services Ltd Back
Registered Office:
5th Flr D Block iLabs Centre,Plot 18 Software Units Sy.#.64, Hyderabad - 500081, Telangana, India. Phone : +91 40 4240 8039   Fax:
Email :
Website :
Initial public offering of 18,943,020 equity shares of face value of Rs.2/- each ("equity shares") of Nephrocare Health Services Limited ("the company" or the "company" or the "issuer") for cash at a price of Rs.460/- per equity share face value of Rs.2/- (including a securities premium of Rs.458/- per equity share) ("offer price") aggregating to Rs.871.05 crores ("offer") comprising a fresh issue of 7,690,162 equity shares of face value of Rs.2/- each aggregating to Rs.353.41 crores ("fresh issue") and an offer for sale of 11,253,102 equity shares of face value of Rs.2/- each ("offered shares") aggregating to Rs.517.64 crores , comprising an offer for sale of 1,521,728 equity shares of face value of Rs.2/- each aggregating to Rs.70.00 crores by Investcorp Private Equity Fund II and 1,604,907 equity shares of face value of Rs.2/- each aggregating to Rs.73.83 crores by Healthcare Parent Limited and 147,765 equity shares of face value of Rs.2/- each aggregating to Rs.6.80 crores by Investcorp Growth Opportunity Fund and 2,888,911 equity shares of face value of Rs.2/- each aggregating to Rs.132.89 crores by Edoras Investment Holdings Pte. Ltd. ("promoter selling shareholders") and 121,985 equity shares of face value of Rs.2/- each aggregating to Rs.5.61 crores by Investcorp India Private Equity Opportunity Limited and 3,089,663 equity shares of face value of Rs.2/- each aggregating to Rs.142.12 crores by International Finance Coproration and 1,433,468 equity shares of face value of Rs.2/- each aggregating to Rs.65.94 crores by 360 One Special Opportunities Fund - Series 9 and 444,675 equity shares of face value of Rs.2/- each aggregating to Rs.20.46 crores by 360 One Special Opportunities Fund - Series 10 ("other selling shareholders" and together with the promoter selling shareholders, the "selling shareholders" and such offer for sale by the selling shareholders, the "offer for sale"). The offer constituted 18.88% of the post-offer paid-up equity share capital of the company.
Issue
Opens On Closes On
10-Dec-25 12-Dec-25
Money Payable On
Application Allotment
460.00 0.00
Minimum Application for shares in Nos : 32 Further Multiples of : 32
(₹)(Cr.) Lead Managers to the Issue
Project Cost (₹) 325.15 Ambit Private Limited
Project Financed through Current Offer (₹) 871.05  
Post Issue Equity Share Capital (₹) 20.07  
Issue Price (₹) 460.00  
Projects
Capital expenditure by our Company for opening new dialysis clinics in India
Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by our Company
General corporate purposes
Promoted By
Vikram Vuppala
Bessemer Venture Partners Trus
Edoras Investment Holdings Pte
Listing At
BSE
NSE
Registrar to the Issue
KFin Techologies Ltd
Mandatory Dematerialization for Transfer of Securities, w.e.f 5th December 2018. Refer to SEBI notification number SEBI/LAD-NRO/GN/2018/24 dated June 08,2018. Update/Link your Aadhaar Number with your Demat Account by submitting a photocopy of Aadhaar card along with a request letter/Modification form. Prevent Unauthorised transactions in your account. Update your mobile numbers & email IDs with your stock brokers. Prevent unauthorized transactions in your trading account. Update your mobile numbers/email IDs with your stock brokers. Receive information/alerts of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
Prevent Unauthorized Transactions in your demat account. Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day. Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment.

Filing Complaints on SCORES

Easy & quick.

  1. Register on SCORES portal.
  2. Provide mandatory details for filing complaints on SCORES like name, PAN, address, mobile number and email ID.
  3. Benefits:
    • Effective communication.
    • Speedy redressal of grievances.

Dear Investor,

As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in the securities market.

In this connection, please visit the BSE Investor Protection Fund Website where you will find useful educational material in the form of text and videos to help you become a well-informed investor.

We believe that an educated investor is a protected investor!

Risk Disclosure on Derivatives

  • 9 out of 10 individual traders in the Equity Futures and Options Segment incurred net losses.
  • On average, loss-making traders registered a net trading loss of approximately ₹50,000.
  • In addition to the net trading losses incurred, loss-makers spent an additional 28% of their net trading losses on transaction costs.
  • Traders making net profits incurred transaction costs ranging from 15% to 50% of their profits.

Source:

SEBI Study dated January 25, 2023 – Analysis of Profit and Loss of Individual Traders dealing in Equity Futures and Options (F&O) Segment


Client may request for voluntary freezing / blocking the online access to their trading account through any one of the following modes that shall be made by sending an Email to stoptrade@magnum.co.in Calling on Mobile No. 9820310090.

MAGNUM EQUITY BROKING LTD.

SEBI Registration No.: INZ000172031 NSE Member ID: 06529 | BSE Clearing No.:126 | CDSL SEBI Registration No. IN-DP-CDSL-201-2003
DP ID: 12029700 | CIN: U67120MH1996PLC103441

Investor Grievances: grievances@magnum.co.in

Copyright © 2018-2019 Magnum Equity Broking Ltd. All rights reserved

Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)